General Information of Drug (ID: DM1EAPF)

Drug Name
DBI-001
Indication
Disease Entry ICD 11 Status REF
Tinea pedis 1F28.2 Phase 2 [1]
Cross-matching ID
TTD ID
D4DK2R

References

1 ClinicalTrials.gov (NCT04152226) Open Label, Single-dose, Dose Escalating Evaluation of the Safety and Tolerability of DBI-001 in Patients With T. Pedis. U.S. National Institutes of Health.